Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03304106 · ClinicalTrials.gov registry record · NA
Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population
A NA study of Cochlear Implant and Sensorineural Hearing Loss, Bilateral, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 9
- Study locations
NCT03304106: Completed NA study of Cochlear Implant and Sensorineural Hearing Loss, Bilateral, sponsored by Cochlear.
NCT03304106 is a NA study of Cochlear Implant and Sensorineural Hearing Loss, Bilateral that has completed, run by Cochlear. The registered enrollment target is 102 participants, below the 125-participant average among 4 other Cochlear Implant trials with a reported enrollment target (18% lower). The trial reports 9 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03304106, a NA study of Cochlear Implant and Sensorineural Hearing Loss, Bilateral, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 9
- Study locations
Study Summary
Use of Artificial Intelligent (AI) technology to assist audiologists in programming cochlear implants.
Primary Outcome
Monosyllabic word recognition was scored in quiet using Consonant-Nucleus-Consonant (CNC) words. Scores are listed as percentage correct thus a higher score (percentage) means a better outcome.Group 1: Preoperative to postoperative percentage performance after 6 months of cochlear implant use. Group 2: Visit A to Visit B after 1 month of cochlear implant use.
Conditions Studied
Interventions
- DEVICE Commercially available cochlear implant and AI system
Study Locations (9)
Colorado
- Rocky Mountain Ear Center - Englewood
Maryland
- Greater Baltimore Medical Center - Baltimore
Michigan
- University of Michigan - Ann Arbor
Missouri
- Midwest Ear Institute - Kansas City
New York
- New York University - New York
Oklahoma
- Hearts for Hearing - Oklahoma City
Tennessee
- Vanderbilt University Medical Center - Nashville
Texas
- Cochlear Hearing Center Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2017-10-19 |
| Est. Completion | 2019-09-18 |
| Phase | NA |
What the finished NCT03304106 record still lists
NCT03304106 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 125-participant average among 4 other Cochlear Implant trials with a reported enrollment target (18% lower).
The record links to 2 conditions, with Cochlear Implant appearing as the primary indexed condition, and to 1 intervention - of which Commercially available cochlear implant and AI system is the first listed.
NCT03304106 lists 9 locations in 9 states (Colorado, Maryland, Michigan).
Frequently Asked Questions
What is clinical trial NCT03304106 about?
NCT03304106 is a clinical study titled "Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population". Use of Artificial Intelligent (AI) technology to assist audiologists in programming cochlear implants.
What is the current status of trial NCT03304106?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2017-10-19. Estimated completion is 2019-09-18.
What conditions does trial NCT03304106 study?
This clinical trial studies the following conditions: Cochlear Implant, Sensorineural Hearing Loss, Bilateral.
What interventions are being tested in trial NCT03304106?
The interventions under investigation include: Commercially available cochlear implant and AI system (DEVICE).
Who is sponsoring clinical trial NCT03304106?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03304106 being conducted?
This trial has 9 study locations across Colorado, Maryland, Michigan, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cochlear Implant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Combined Electric and Acoustic Hearing (EAS) in Children and Adults
RECRUITING · NA
-
MED-EL Remote Care Multi-Center Feasibility Study
RECRUITING · NA
-
AB-Intra- and Post-Operative Measures of Auditory Function
COMPLETED · NA
-
Binaural Cue Sensitivity in Children and Adults With Combined Electric and Acoustic Stimulation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI